TrialOpen forum infectious diseases2025

Early Experience and Effectiveness of Long-Acting Injectable Cabotegravir and Rilpivirine in a South Side Chicago HIV Clinic.

Geoffroy Liegeon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.